Senior Director, Metabolic Clinical Development (MASH)

Merck; Boston (MA); On-site; USD 282,000 - 444,000; Full time

Job summary

Merck seeks a Senior Director (Sr. Principal Scientist) to plan and direct clinical research in Metabolism, with focus on MASH and obesity-related disorders across all development phases.

The Senior Director will drive strategy, study design, initiation, execution, monitoring, analysis, regulatory reporting and publication. The role requires leading cross-functional teams, collaborating with Clinical Scientists, regulatory, statistics and manufacturing to advance our medicines and deliver

Qualifications

• MD or MD/PhD required.
• Minimum of 3 years of experience in clinical medicine.
• Minimum of 3-5 years of industry experience in drug development or biomedical research in academia.

Responsibilities

• Plan clinical trials (design, operational plans, settings) based on clinical development strategies.
• Monitor and manage the conduct of ongoing or new clinical trials for investigational or marketed drugs.
• Analyze and summarize clinical findings to support safety/efficacy decisions and regulatory documents.
• Participate in internal and joint research project teams for development of new compounds and marketed drugs.
• Evaluate pre-clinical/translational work for early development plans and INDs; develop development strategies.

Skills

Cardiology

Clinical Development

Clinical Trials

Drug Development

Endocrinology

Hepatology

Liver Diseases

Nephrology

Obesity

Pharmaceutical Industry

Education

M.D or M.D./Ph.D.

Job description

Merck seeks a Senior Director (Sr. Principal Scientist) to plan and direct clinical research in Metabolism, with focus on MASH and obesity-related disorders across all development phases.

The Senior Director will drive strategy, study design, initiation, execution, monitoring, analysis, regulatory reporting and publication. The role requires leading cross-functional teams, collaborating with Clinical Scientists, regulatory, statistics and manufacturing to advance our medicines and deliver